Hologic (HOLX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tejas Savant ...

Analyst Michael Matson from Needham reiterated a Buy rating on Hologic (HOLX – Research Report) and keeping the price target at $90.00.

Good afternoon, and welcome to the Hologic's Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Shelly, and I am your operator for today’s call. Today's conference is being recorded. All ...

Paul C. Lin, M.D. Because of its technical simplicity and significant impact on improving reproductive capacity, I advocate surgical removal of the uterine septum, especially in women diagnosed ...